Biocon 'welcomes' India's duty exemptions on cancer, chronic disease drugs
Peter Bains, Group CEO of Biocon, talks about India's budget, and the impact of its plans to cut or remove duties on ...
FOX 32 Chicago on MSN6h
Crews still removing debris from Philadelphia plane crash site
Investigators are still trying to figure out what exactly went wrong when a medical jet crashed in Philadelphia just moments ...
Investing3h
Galderma stock faces tariff exposure, RBC notes
On Monday, RBC (TSX: RY) analysts highlighted potential risks for Galderma stock due to newly imposed 25% tariffs on imports from Canada by the United States.